VPS Lakeshore Hospital has become the first healthcare centre in India to successfully complete 100 Charcot foot reconstructive surgeries, marking a major milestone in the treatment of one of the most serious yet often overlooked complications of diabetes.
The achievement was announced by the hospital’s Centre of Excellence in Foot and Ankle Surgery and Podiatry during a press conference held in Kochi on Wednesday. Established in 2022, the centre has emerged as a leading referral destination for patients with complex foot and ankle disorders from across India and neighbouring countries.
Speaking at the event, Dr. Rajesh Simon, Head of Department and Senior Consultant, Foot and Ankle Surgery, said Charcot neuropathic foot is among the most frequently misdiagnosed complications affecting people with diabetes. The condition weakens the bones and joints of the foot, leading to deformities, instability, infections, and, in severe cases, amputation.
“Early diagnosis, multidisciplinary care, and reconstructive surgery can help restore stability, preserve the limb, and improve mobility,” Dr. Simon said.
Dr. Simon, who is also the first Indian Vice-President of the Asian Federation of Foot and Ankle Surgeons (AFFAS), highlighted the growing burden of diabetes-related foot complications in India. He noted that timely intervention can significantly reduce the risk of amputation and improve quality of life for patients.
Dr. Dennis P. Jose, Consultant in Foot and Ankle Surgery, explained that diabetic patients often fail to notice minor injuries due to reduced sensation in their feet. Such injuries can progress into ulcers, infections, and severe complications if left untreated. He stressed the importance of detailed vascular and neuropathic assessments for early identification of high-risk patients.
Managing Director S.K. Abdulla said the hospital’s specialised Foot and Ankle Division has helped many patients avoid amputation through advanced treatment and timely care. He added that the hospital plans to strengthen preventive care, early detection, and rehabilitation services in the future.
Group CEO Abhishek Poduri emphasised the need for greater public awareness about Charcot foot, urging people with diabetes to seek timely medical attention to prevent disability and improve long-term outcomes.
Author
